Data from the literature hypothesize that traditional Chinese medicinal herbs might increase efficacy while reducing toxicity if administered in combination with PKI, i.e., EGFR-TKI for Advanced Non-Small-Cell Lung Cancer [246]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.